866-997-4948(US-Canada Toll Free)

United States Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Report 2017

Published By :

QYResearch

Published Date : Feb 2017

Category :

Cancer

No. of Pages : 121 Pages

Notes:
Sales, means the sales volume of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs)
Revenue, means the sales value of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs)

This report studies sales (consumption) of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering
Janssen
Qiagen
Advanced Cell Diagnostics
ApoCell
Biofluidica
Clearbridge Biomedics
CytoTrack
Celsee
Fluxion
Gilupi
Cynvenio
On-chip
YZY Bio
BioView
Creatv MicroTech
Fluidigm
Ikonisys
AdnaGen
IVDiagnostics
Miltenyi Biotec
Aviva Biosciences Corporation
ScreenCell
Silicon Biosystems

Market Segment by States, covering
California
Texas
New York
Florida
Illinois
Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
CellSearch
Other
Split by applications, this report focuses on sales, market share and growth rate of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) in each application, can be divided into
Breast Cancer Diagnosis and Treatment
Prostate Cancer Diagnosis and Treatment
Colorectal Cancer Diagnosis and Treatment
Lung Cancer Diagnosis and Treatment
Other Cancers Diagnosis and Treatment

Table of Contents

United States Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Report 2017
1 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Overview
1.1 Product Overview and Scope of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs)
1.2 Classification of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs)
1.2.1 CellSearch
1.2.2 Other
1.3 Application of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs)
1.3.1 Breast Cancer Diagnosis and Treatment
1.3.2 Prostate Cancer Diagnosis and Treatment
1.3.3 Colorectal Cancer Diagnosis and Treatment
1.3.4 Lung Cancer Diagnosis and Treatment
1.3.5 Other Cancers Diagnosis and Treatment
1.4 United States Market Size Sales (Volume) and Revenue (Value) of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) (2012-2022)
1.4.1 United States Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales and Growth Rate (2012-2022)
1.4.2 United States Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate (2012-2022)

2 United States Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Competition by Manufacturers
2.1 United States Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Average Price by Manufactures (2015 and 2016)
2.4 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Competitive Situation and Trends
2.4.1 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Concentration Rate
2.4.2 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion

3 United States Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales (Volume) and Revenue (Value) by States (2012-2017)
3.1 United States Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales and Market Share by States (2012-2017)
3.2 United States Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Market Share by States (2012-2017)
3.3 United States Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Price by States (2012-2017)

4 United States Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales (Volume) and Revenue (Value) by Type (2012-2017)
4.1 United States Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales and Market Share by Type (2012-2017)
4.2 United States Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Market Share by Type (2012-2017)
4.3 United States Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Price by Type (2012-2017)
4.4 United States Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales Growth Rate by Type (2012-2017)

5 United States Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales (Volume) by Application (2012-2017)
5.1 United States Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales and Market Share by Application (2012-2017)
5.2 United States Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 United States Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Manufacturers Profiles/Analysis
6.1 Janssen
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Type, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Janssen Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Qiagen
6.2.2 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Type, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Qiagen Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Advanced Cell Diagnostics
6.3.2 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Type, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Advanced Cell Diagnostics Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 ApoCell
6.4.2 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Type, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 ApoCell Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Biofluidica
6.5.2 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Type, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Biofluidica Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Clearbridge Biomedics
6.6.2 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Type, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Clearbridge Biomedics Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 CytoTrack
6.7.2 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Type, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 CytoTrack Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Celsee
6.8.2 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Type, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Celsee Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Fluxion
6.9.2 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Type, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Fluxion Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 Gilupi
6.10.2 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Product Type, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Gilupi Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview
6.11 Cynvenio
6.12 On-chip
6.13 YZY Bio
6.14 BioView
6.15 Creatv MicroTech
6.16 Fluidigm
6.17 Ikonisys
6.18 AdnaGen
6.19 IVDiagnostics
6.20 Miltenyi Biotec
6.21 Aviva Biosciences Corporation
6.22 ScreenCell
6.23 Silicon Biosystems

7 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Manufacturing Cost Analysis
7.1 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs)

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Major Manufacturers in 2015
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Forecast (2017-2022)
11.1 United States Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales, Revenue Forecast (2017-2022)
11.2 United States Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales Forecast by Type (2017-2022)
11.3 United States Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales Forecast by Application (2017-2022)
11.4 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Price Forecast (2017-2022)

12 Research Findings and Conclusion

13 Appendix
Methodology
Analyst Introduction
Data Source

List of Table

List of Tables and Figures

Figure Picture of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs)
Table Classification of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs)
Figure United States Sales Market Share of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) by Type in 2015
Figure CellSearch Picture
Figure Other Picture
Table Application of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs)
Figure United States Sales Market Share of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) by Application in 2015
Figure Breast Cancer Diagnosis and Treatment Examples
Figure Prostate Cancer Diagnosis and Treatment Examples
Figure Colorectal Cancer Diagnosis and Treatment Examples
Figure Lung Cancer Diagnosis and Treatment Examples
Figure Other Cancers Diagnosis and Treatment Examples
Figure United States Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales and Growth Rate (2012-2022)
Figure United States Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate (2012-2022)
Table United States Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales of Key Manufacturers (2015 and 2016)
Table United States Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales Share by Manufacturers
Figure 2016 Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales Share by Manufacturers
Table United States Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue by Manufacturers (2015 and 2016)
Table United States Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue Share by Manufacturers
Table 2016 United States Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue Share by Manufacturers
Table United States Market Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Average Price of Key Manufacturers in 2015
Figure Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share of Top 3 Manufacturers
Figure Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Share of Top 5 Manufacturers
Table United States Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales by States (2012-2017)
Table United States Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales Share by States (2012-2017)
Figure United States Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales Market Share by States in 2015
Table United States Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Market Share by States (2012-2017)
Table United States Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue Share by States (2012-2017)
Figure Revenue Market Share of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) by States (2012-2017)
Table United States Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Price by States (2012-2017)
Table United States Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales by Type (2012-2017)
Table United States Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales Share by Type (2012-2017)
Figure United States Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales Market Share by Type in 2015
Table United States Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Market Share by Type (2012-2017)
Table United States Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) by Type (2012-2017)
Table United States Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Price by Type (2012-2017)
Figure United States Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales Growth Rate by Type (2012-2017)
Table United States Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales by Application (2012-2017)
Table United States Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales Market Share by Application (2012-2017)
Figure United States Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales Market Share by Application in 2015
Table United States Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales Growth Rate by Application (2012-2017)
Figure United States Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales Growth Rate by Application (2012-2017)
Table Janssen Basic Information List
Table Janssen Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Janssen Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales Market Share (2012-2017)
Table Qiagen Basic Information List
Table Qiagen Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales, Revenue, Price and Gross Margin (2012-2017)
Table Qiagen Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales Market Share (2012-2017)
Table Advanced Cell Diagnostics Basic Information List
Table Advanced Cell Diagnostics Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales, Revenue, Price and Gross Margin (2012-2017)
Table Advanced Cell Diagnostics Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales Market Share (2012-2017)
Table ApoCell Basic Information List
Table ApoCell Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales, Revenue, Price and Gross Margin (2012-2017)
Table ApoCell Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales Market Share (2012-2017)
Table Biofluidica Basic Information List
Table Biofluidica Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales, Revenue, Price and Gross Margin (2012-2017)
Table Biofluidica Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales Market Share (2012-2017)
Table Clearbridge Biomedics Basic Information List
Table Clearbridge Biomedics Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales, Revenue, Price and Gross Margin (2012-2017)
Table Clearbridge Biomedics Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales Market Share (2012-2017)
Table CytoTrack Basic Information List
Table CytoTrack Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales, Revenue, Price and Gross Margin (2012-2017)
Table CytoTrack Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales Market Share (2012-2017)
Table Celsee Basic Information List
Table Celsee Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales, Revenue, Price and Gross Margin (2012-2017)
Table Celsee Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales Market Share (2012-2017)
Table Fluxion Basic Information List
Table Fluxion Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales, Revenue, Price and Gross Margin (2012-2017)
Table Fluxion Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales Market Share (2012-2017)
Table Gilupi Basic Information List
Table Gilupi Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales, Revenue, Price and Gross Margin (2012-2017)
Table Gilupi Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales Market Share (2012-2017)
Table Cynvenio Basic Information List
Table On-chip Basic Information List
Table YZY Bio Basic Information List
Table BioView Basic Information List
Table Creatv MicroTech Basic Information List
Table Fluidigm Basic Information List
Table Ikonisys Basic Information List
Table AdnaGen Basic Information List
Table IVDiagnostics Basic Information List
Table Miltenyi Biotec Basic Information List
Table Aviva Biosciences Corporation Basic Information List
Table ScreenCell Basic Information List
Table Silicon Biosystems Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs)
Figure Manufacturing Process Analysis of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs)
Figure Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Industrial Chain Analysis
Table Raw Materials Sources of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Major Manufacturers in 2015
Table Major Buyers of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs)
Table Distributors/Traders List
Figure United States Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Production and Growth Rate Forecast (2017-2022)
Figure United States Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue and Growth Rate Forecast (2017-2022)
Table United States Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Production Forecast by Type (2017-2022)
Table United States Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Consumption Forecast by Application (2017-2022)
Table United States Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales Forecast by States (2017-2022)
Table United States Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Sales Share Forecast by States (2017-2022)

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *